[go: up one dir, main page]

LT3168214T - Pakeisti 2-tiokso-imidazolidin-4-onai ir jų spiro analogai, aktyvi priešvėžinė sudedamoji dalis, farmacinė kompozicija, medicininis paruošimas, prostatos vėžio gydymo būdas - Google Patents

Pakeisti 2-tiokso-imidazolidin-4-onai ir jų spiro analogai, aktyvi priešvėžinė sudedamoji dalis, farmacinė kompozicija, medicininis paruošimas, prostatos vėžio gydymo būdas

Info

Publication number
LT3168214T
LT3168214T LTEP15818878.9T LT15818878T LT3168214T LT 3168214 T LT3168214 T LT 3168214T LT 15818878 T LT15818878 T LT 15818878T LT 3168214 T LT3168214 T LT 3168214T
Authority
LT
Lithuania
Prior art keywords
composition
thyxo
anticipal
analoges
imidazolidin
Prior art date
Application number
LTEP15818878.9T
Other languages
English (en)
Inventor
Alexandre Vasilievich IVACHTCHENKO
Original Assignee
R-Pharm Overseas Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R-Pharm Overseas Inc. filed Critical R-Pharm Overseas Inc.
Publication of LT3168214T publication Critical patent/LT3168214T/lt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/86Oxygen and sulfur atoms, e.g. thiohydantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41661,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41881,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/16Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C229/54Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C229/60Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in meta- or para- positions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/107Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Furan Compounds (AREA)
LTEP15818878.9T 2014-07-08 2015-06-26 Pakeisti 2-tiokso-imidazolidin-4-onai ir jų spiro analogai, aktyvi priešvėžinė sudedamoji dalis, farmacinė kompozicija, medicininis paruošimas, prostatos vėžio gydymo būdas LT3168214T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2014127705/04A RU2557235C1 (ru) 2014-07-08 2014-07-08 Замещенные 2-тиоксо-имидазолидин-4-оны и их спироаналоги, противораковый активный компонент, фармацевтическая композиция, лекарственный препарат, способ лечения рака простаты
PCT/RU2015/000395 WO2016007046A1 (ru) 2014-07-08 2015-06-26 Замещенные 2-тиоксо-имидазолидин-4-оны и их спироаналоги, противораковый активный компонент, фармацевтическая композиция, лекарственный препарат, способ лечения рака простаты

Publications (1)

Publication Number Publication Date
LT3168214T true LT3168214T (lt) 2019-07-25

Family

ID=53611746

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP15818878.9T LT3168214T (lt) 2014-07-08 2015-06-26 Pakeisti 2-tiokso-imidazolidin-4-onai ir jų spiro analogai, aktyvi priešvėžinė sudedamoji dalis, farmacinė kompozicija, medicininis paruošimas, prostatos vėžio gydymo būdas

Country Status (23)

Country Link
US (1) US10450278B2 (lt)
EP (1) EP3168214B1 (lt)
JP (1) JP6581193B2 (lt)
KR (1) KR102171120B1 (lt)
AU (1) AU2015288381B2 (lt)
CA (1) CA2954401C (lt)
CY (1) CY1122231T1 (lt)
DK (1) DK3168214T3 (lt)
ES (1) ES2736507T3 (lt)
GE (1) GEP20207096B (lt)
HR (1) HRP20191265T8 (lt)
HU (1) HUE044317T2 (lt)
LT (1) LT3168214T (lt)
PL (1) PL3168214T3 (lt)
PT (1) PT3168214T (lt)
RS (1) RS59009B1 (lt)
RU (1) RU2557235C1 (lt)
SI (1) SI3168214T1 (lt)
SM (1) SMT201900379T1 (lt)
TR (1) TR201910220T4 (lt)
UA (1) UA117626C2 (lt)
WO (1) WO2016007046A1 (lt)
ZA (1) ZA201700922B (lt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3030181A1 (en) * 2016-07-08 2018-01-11 Janssen Pharmaceutica Nv Substituted hydantoin and thiohydantoin derivatives as androgen receptor antagonists
CN107954936B (zh) * 2016-10-17 2021-03-19 海创药业股份有限公司 一种制备氘代咪唑二酮类化合物的方法
CN109422725A (zh) * 2017-09-04 2019-03-05 北京美倍他药物研究有限公司 前列腺癌治疗药物
RU2708253C2 (ru) * 2017-12-05 2019-12-05 Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Новые производные арил-тиогидантоина, ингибиторы андрогенового рецептора, способ получения и применения
BR112021011968A2 (pt) * 2018-12-19 2021-09-08 Celgene Corporation Compostos de 3-((3-aminofenil)amino)piperidina-2,6-diona substituídos, composições dos mesmos e métodos de tratamento com os mesmos
TW202039434A (zh) * 2018-12-19 2020-11-01 美商西建公司 經取代之3-((3-胺基苯基)胺基)哌啶-2,6-二酮化合物、其組合物及使用彼等之治療方法
CN114621109B (zh) * 2020-12-14 2024-04-26 成都苑东生物制药股份有限公司 一种阿帕他胺的合成方法及其中间体
CN113698310B (zh) * 2021-08-20 2023-03-17 江西金丰药业有限公司 一种恩杂鲁胺双酯中间体的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS53967B1 (sr) * 2005-05-13 2015-08-31 The Regents Of The University Of California Diaril hidantoin jedinjenja kao antagonisti receptora androgena za lečenje raka
BRPI1007990A2 (pt) * 2009-02-24 2015-09-01 Medivation Prostate Therapeutics Inc Compostos específicos de diaril-hidantoína e diariltioidantoína.
AU2011218173C1 (en) * 2010-02-16 2015-04-16 Aragon Pharmaceuticals, Inc. Androgen receptor modulators and uses thereof
SI3329775T1 (sl) * 2010-02-24 2021-09-30 Medivation Prostate Therapeutics Llc Procesi za sintezo spojin diariltiohidantoina in diarilhidantoina
RU2434851C1 (ru) * 2010-07-22 2011-11-27 Александр Васильевич Иващенко Циклические n, n'-диарилтиомочевины или n, n'-диарилмочевины - антагонисты андрогенных рецепторов, противораковое средство, способ получения и применения
RU2520134C1 (ru) * 2013-02-27 2014-06-20 Общество с ограниченной ответственностью "Авионко" (ООО "Авионко") Замещенные (r)-3-(4-метилкарбамоил-3-фторфениламино)-тетрагидро-фуран-3-енкарбоновые кислоты и их эфиры, способ их получения и применения

Also Published As

Publication number Publication date
KR20170023184A (ko) 2017-03-02
JP2017522379A (ja) 2017-08-10
GEP20207096B (en) 2020-04-10
RU2557235C1 (ru) 2015-07-20
PT3168214T (pt) 2019-07-25
EP3168214A4 (en) 2018-02-14
EP3168214B1 (en) 2019-04-24
HRP20191265T8 (hr) 2019-11-01
WO2016007046A1 (ru) 2016-01-14
DK3168214T3 (da) 2019-07-22
SMT201900379T1 (it) 2019-09-09
US10450278B2 (en) 2019-10-22
US20180179164A1 (en) 2018-06-28
AU2015288381A1 (en) 2017-03-02
SI3168214T1 (sl) 2019-09-30
CA2954401A1 (en) 2016-01-14
KR102171120B1 (ko) 2020-10-29
UA117626C2 (uk) 2018-08-27
ES2736507T3 (es) 2020-01-02
RS59009B1 (sr) 2019-08-30
AU2015288381B2 (en) 2019-11-07
PL3168214T3 (pl) 2019-10-31
HUE044317T2 (hu) 2019-10-28
CY1122231T1 (el) 2020-11-25
ZA201700922B (en) 2019-08-28
HRP20191265T1 (hr) 2019-10-18
CA2954401C (en) 2021-03-02
TR201910220T4 (tr) 2019-07-22
EP3168214A1 (en) 2017-05-17
JP6581193B2 (ja) 2019-09-25

Similar Documents

Publication Publication Date Title
IL260383B (en) Low dose medication
PH12016501139B1 (en) Bicyclic heterocycle compounds and their uses in therapy
LT2943192T (lt) Kasos vėžio gydymo būdai, apimantys paklitakselį ir gemcitabiną
LT3168214T (lt) Pakeisti 2-tiokso-imidazolidin-4-onai ir jų spiro analogai, aktyvi priešvėžinė sudedamoji dalis, farmacinė kompozicija, medicininis paruošimas, prostatos vėžio gydymo būdas
DK2986304T3 (da) Farmaceutisk sammensætning, fremgangsmåder til behandling og anvendelser deraf.
BR112016018062A2 (pt) compostos terapêuticos, composição farmacêutica e usos
IL276733A (en) Use of Aribolin in cancer treatment
IL258246B (en) Isolidine compound, pharmaceutical compositions comprising same, their combinations with therapeutic agents for use in the treatment of cancer
LT3200815T (lt) Būdai ir kompozicijos, skirti vėžio gydymui
LT3371179T (lt) Nauji kriptoficino junginiai ir konjugatai, jų gavimas ir terapinis panaudojimas
LT3069720T (lt) Farmacinė kompozicija, kurios sudėtyje yra glutarimido dariniai, ir jų panaudojimas eozinofilinių ligų gydymui
EP3581183A4 (en) PHARMACEUTICAL COMPOSITION FOR ONCOTHERAPY
LT4124339T (lt) Vaisto įvedimo sistemos ir būdai šlapimo pūslės vėžiui gydyti gemcitabinu
SG11201605868XA (en) Pharmaceutical composition for cancer treatment and pharmaceutical preparation for cancer treatment containing same composition as active ingredient
IL245738A0 (en) Oxindole derivatives, ways of their preparation and their therapeutic use in the treatment of ampk-related diseases
BR112017013012A2 (pt) compostos de indenil, composições farmacêuticas e usos médicos destes
IL249860A0 (en) Pharmaceutical preparations, methods for their preparation and their use for the treatment of cancer
ZA201608558B (en) Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases
IL274177A (en) Medical substances, their preparation and diagnostic method
EP3153178A4 (en) Method for treating cancer patients using folr1 targeted drug and antifolate, and drug
IL251930A0 (en) Anylhydroxy derivatives, their preparation and medical uses
BR112018002732A2 (pt) Agente terapêutico para tumor
GB2553684B (en) Ethynylxanthines, preparation and use for cancer treatment
DK3092039T3 (da) Hudcancerbehandling med strålingsterapi
BR112017005002A2 (pt) macropinocitose de anticorpos anti-cd46 humanos e agentes terapêuticos dirigidos contra o câncer.